… challenges for therapeutic strategies in CVDs. We discuss the main epigenetic mechanisms
involved in atherosclerosis, coronary heart disease (CHD), HF, MI, and cardiac hypertrophy. …

Chronic obstructive pulmonary disease (COPD) and heart failure (CHF) are common conditions.
The prevalence of COPD ranges from 20% to 30% in patients with CHF. The diagnosis …

… The prevalence of hypertensive heart disease (HHD) has increased over the last … this disease
[1]. Furthermore, AHT remains the most important risk factor for ischemic heart disease with …

… In these diseases, the precise identity of the … in therapeutically targeting the inflammatory
response. Although there has been success with anti-inflammatory therapy in chronic diseases …

… modulation of disease mechanisms. Here, we summarize current knowledge of the roles of
miRNAs in heart disease and consider the advantages and potential challenges of microRNA…

… Heart failure is the final manifestation of CVD and cardiac injury, as well as less common but
important etiologies including cardiomyopathies, valvular heart disease… -based therapeutics …

… Whether lncRNAs can be therapeutically targeted in a comparable manner as … challenges
in using noncoding RNAs as therapeutic targets for the treatment of cardiovascular diseases. …

… for the occurrence and development of ventricular dilatation and heart failure. MF is the
pathological basis of hypertensive heart disease (HHD), and blood pressure control is the key to …

… Abstract: Coronary heart disease (CHD) is the leading cause … Finally, challenges and
opportunities facing application of … AS is the main cause of coronary heart disease (CHD), which …

… A major challenge for the future will be to identify the mRNA targets of the … for therapeutically
exploiting the biology of miRNAs in the settings of congenital and acquired heart disease, …